<PAGE> OMB Number 3235-0287
Expires: September 30, 1998
Estimated average burden
hours per response 0.5
FORM 4
/XX/ Check this box if no longer
subject to Section 16. Form 4 or
Form 5 obligations may continue.
See Instruction 1(b).
U.S. SECURITIES AND EXCHANGE COMMISSION
Washington, D. C. 20549
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP
Filed pursuant to Section 16(a) of the Securities Exchange Act of
1934,
Section 17(a) of the Public Utility Holding Company Act of 1935
or Section 30(f) of the Investment Company Act of 1940
(Print or Type Responses)
1. Name and Address of Reporting Person*
<< LYNX HEALTHTECH FUND, LLC
2601 Fair Oaks Boulevard, Sacramento, CA 95864 >>
______________________________________________________________________
(Last) (First) (Middle), (Street), (City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
<< Provident American Corporation (PAMC) >>
3. IRS or Social Security Number of Reporting Person (Voluntary) ________
4. Statement for Month/Year
<< 11-98 >>
5. If Amendment, Date of Original (Month/Year) ___________
6. Relationship of reporting person to issuer
(Check all applicable)
____ Director ____ 10% Owner
____ Officer (give XXXX Other (specify
title below) below)
<< Former 10% Owner. >>
7. Individual or Joint/Group Filing (Check Applicable line)
XXXX Form filed by one Reporting Person
____ Form filed by More than One Reporting Person
SEC 1474 (7-96)
<PAGE>
FORM 4 (continued) Page 2 of 4 Pages
Table I - Non-Derivative Securities Acquired, Disposed of,
or Beneficially Owned
1. Title of Security (Instr. 3)
<< COMMON STOCK >>
2. Transaction Date (Month/Day/Year)
<< November 20, 1998 >>
3. Transaction Code (Instr. 8)
Code V
<< J __________ >>
4. Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)
Amount (A) or (D) Price
<< 58,000 D $N/A >>
5. Amount of Securities Beneficially Owned at End of Month
(Inst. 3 and 4)
<< 127,900 >>
6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)
<< D >>
7. Nature of Indirect Beneficial Ownership (Inst. 4)
___________________________________________________________________________
<PAGE>
FORM 4 (continued) Page 3 of 4 Pages
Table II - Derivative Securities Acquired, Disposed of,
or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible
securities)
1. Title of Derivative Security (Instr. 3)
2. Conversion or Exercise Price of Derivative Security
3. Transaction Date (Month/Day/Year)
4. Transaction Code (Instr. 8)
Code V
___________` ____________
5. Number of Derivative Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4, and 5)
(A) _____________ (D) ______________
6. Date Exercisable and Expiration Date (Month/Day/Year)
Date Exercisable Expiration Date
7. Title and Amount of Securities Underlying Derivative Security
(Instr. 3 and 4)
Title Amount or Number of Shares
_______________________ ___________________________
8. Price of Derivative Security (Instr. 5)
$____________________
9. Number of derivative Securities Beneficially Owned at End of Month
(Instr. 4)
________________________
10. Ownership Form of Derivative Security: Direct (D) or Indirect (I)
(Instr. 4)
11. Nature of Indirect Beneficial Ownership (Inst. 4)
<PAGE>
FORM 4 (continued) Page 4 of 4 Pages
Explanation of Responses: LYNX HEALTHTECH FUND, LLC 12/10/98
A member of the Reporting Person Date
withdrew as a member and received By: LYNX CAPITAL GROUP, LLC
a distribution of 58,000 shares
of common stock. By: /s/ Michael Ashker
Michael Ashker, Manager
**Signature of Reporting Person
** Intentional misstatements or omissions of facts constitute
Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed.
If space is insufficient, See Instruction 6 for procedure.
Potential persons who are to respond to the collection
of information contained in this form are not required to respond
unless the form displays a currently valid OMB Number. SEC 1474 (7-96)
4450/12/1018747
